HBLVX
Price
$15.00
Change
+$0.01 (+0.07%)
Updated
Dec 26 closing price
Net Assets
11.68B
UGTIX
Price
$30.22
Change
-$0.01 (-0.03%)
Updated
Dec 26 closing price
Net Assets
896.25M
Interact to see
Advertisement

HBLVX vs UGTIX

Header iconHBLVX vs UGTIX Comparison
Open Charts HBLVX vs UGTIXBanner chart's image
Hartford Balanced Income R6
Price$15.00
Change+$0.01 (+0.07%)
VolumeN/A
Net Assets11.68B
Victory Growth and Tax Strategy Ins
Price$30.22
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets896.25M
HBLVX vs UGTIX Comparison Chart in %
View a ticker or compare two or three
VS
HBLVX vs. UGTIX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLVX is a StrongBuy and UGTIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLVX has more cash in the bank: 11.7B vs. UGTIX (896M). HBLVX pays higher dividends than UGTIX: HBLVX (3.48) vs UGTIX (1.73). HBLVX was incepted earlier than UGTIX: HBLVX (11 years) vs UGTIX (6 years). HBLVX (0.56) and UGTIX (0.55) have similar cost to investors . HBLVX is a more actively managed with annual turnover of: 61.00 vs. UGTIX (17.00). HBLVX has a lower initial minimum investment than UGTIX: HBLVX (0) vs UGTIX (1000000). UGTIX annual gain was more profitable for investors over the last year : 9.13 vs. HBLVX (6.75). UGTIX return over 5 years is better than : 41.19 vs. HBLVX (11.85).
HBLVXUGTIXHBLVX / UGTIX
Total Expense Ratio0.560.54104%
Annual Report Gross Expense Ratio0.560.55102%
Fund Existence11 years6 years-
Gain YTD7.13410.31169%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets11.7B896M1,306%
Annual Yield % from dividends3.481.73201%
Returns for 1 year6.759.1374%
Returns for 3 years19.0144.6343%
Returns for 5 years11.8541.1929%
Returns for 10 years49.69N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIOA14.080.87
+6.59%
BioAge Labs Inc.
UE19.400.35
+1.84%
Urban Edge Properties
ATOS0.69N/A
+0.32%
Atossa Therapeutics
SNN32.840.05
+0.15%
Smith & Nephew plc
CNSP6.20-0.03
-0.48%
CNS Pharmaceuticals Inc